Related Experiment Video
Updated: Sep 27, 2025

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections
Arianna Pani1, Lucini Valeria1, Silvana Dugnani1
1Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
Abstract:
Recurring urinary tract infections (rUTIs) are frequently caused by Escherichia coli, which invades urothelial cells and forms quiescent bacterial reservoirs. D-mannose, an inert monosaccharide, represents a notable agent for rUTI prevention; however, there is no agreement on its dosage. To provide pharmacological basis for an effective dose, we evaluated its ability to inhibit adhesion of E. coli to urothelial cells. E. coli strains isolated from the urine of a woman with recurrent urinary tract infections were selected according to adhesion capacity. Anti-adhesive efficacy and invasion were tested using the TCC-5637 urothelial cell line. The IC50 for the anti-adhesive efficacy and anti-invasion activity of D-mannose were 0.51 mg/ml and 0.30 mg/ml, respectively, both with concentration-dependent inhibition. Lastly, the biofilm interference of D-mannose was evaluated to be 50 mg/ml. D-mannose inhibited the adhesion of E. coli to urothelial cells at high concentrations, whereas inhibition of invasion occurred at much lower concentrations.
Insights
D-mannose effectively prevents recurring urinary tract infections (rUTIs) by inhibiting E. coli adhesion and invasion. This study provides a pharmacological basis for optimal D-mannose dosage in rUTI prevention strategies.
Area of Science:
- Urology
- Microbiology
- Pharmacology
Background:
- Recurring urinary tract infections (rUTIs) are often caused by Escherichia coli.
- E. coli invades urothelial cells, forming bacterial reservoirs.
- D-mannose is a potential agent for rUTI prevention, but optimal dosage is unclear.
Purpose of the Study:
- To determine the effective dosage of D-mannose for preventing E. coli adhesion and invasion.
- To provide a pharmacological basis for D-mannose dosing in rUTI prevention.
Main Methods:
- Selected E. coli strains based on adhesion capacity.
- Tested anti-adhesive and anti-invasion efficacy using TCC-5637 urothelial cells.
- Evaluated D-mannose's biofilm interference.
Main Results:
- The IC50 for D-mannose's anti-adhesive efficacy was 0.51 mg/ml.
- The IC50 for D-mannose's anti-invasion activity was 0.30 mg/ml.
- D-mannose inhibited E. coli adhesion at high concentrations and invasion at lower concentrations. Biofilm interference was observed at 50 mg/ml.
Conclusions:
- D-mannose demonstrates concentration-dependent inhibition of E. coli adhesion and invasion.
- Lower concentrations of D-mannose are effective in inhibiting bacterial invasion.
- Findings support D-mannose as a viable agent for rUTI prevention with specific dosage recommendations.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Cholinergic Antagonists: Pharmacokinetics
Urinary Tract Infection II: Pathophysiology
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

